In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5
- 30 November 1995
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 32 (16) , 1183-1195
- https://doi.org/10.1016/0161-5890(95)00099-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritisArthritis & Rheumatism, 1993
- Mouse Variable‐Region Gene Families: Complexity, Polymorphism and Use in non‐Autoimmune ResponsesImmunological Reviews, 1992
- Purification of native proteins from the cytoplasm and periplasm of Escherichia coli using IMAC and histidine tails: A comparison of proteins and protocolsMethods, 1992
- Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coliBiochemistry, 1991
- The control of homologous lysisImmunology Today, 1991
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardiumClinical and Experimental Immunology, 1990
- Single-Chain Antigen-Binding ProteinsScience, 1988
- Metabolism of complement factor D in renal failureKidney International, 1988
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Journal of Clinical Investigation, 1988